Natco Pharma Limited has informed the Exchange regarding a press release dated December 17, 2020, titled "NATCO launches anti blood clot tablet Rivaroxaban in India".
Press Release Dec 17 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from NATCO Pharma
- NATCO Pharma receives Pomalidomide approval for US market
- Press Release Nov 13 2020
- Press Release Nov 12 2020
- Press Release Sep 30 2020
- NATCO Pharma records INR 582.1 Crore consolidated revenue and INR 122.1 Crore of profit, after tax, for the First Quarter, FY2020-21
Later from NATCO Pharma
- NATCO Pharma launches anti blood clot tablet Rivaroxaban in India
- Press Release Feb 05 2021
- NATCO Pharma receives approval for Chlorantraniliprole 1st key product of Crop Health Sciences Division
- Press Release Feb 26 2021
- NATCO Pharma launches Brivaracetam tablets, in India, for treatment of epilepsy
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma